Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Op-Eds
“Direct Action” The Tactics of Radical Activism: Part 1, How Environmental Groups Use Violent Tactics to Advance their
Full article available as a pdf. <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />July 8, 2000 –Kwajalein Atoll,…
Op-Eds
GMO Patent Nonsense
One of the most contentious issues in the debate over GM crops and foods is the existence of intellectual property protection and patents…
Op-Eds
Patent Nonsense on GMOs Should Be Debunked
It may now seem daring to say, but in a decade's time GM foods are likely to be as widely accepted in kitchens…
Op-Eds
Conko and Prakash Guest Editorial from BioScience News and Advocate
The use of bioengineering technology for the development of new plant varieties has been endorsed by dozens of scientific bodies, has increased crop…
Products
October Edition of the Monthly Planet
Full Document Available in PDF Articles in this edition: “On…
Op-Eds
United Nations Day of Shame
UN Secretary-General Kofi Annan recently declared that the global pursuit of scientific endeavors is marked by inequality. Noting that developing countries invest much…